Evolution and global dissemination of macrolide-resistant group A streptococci

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 9, 2006, Pages 2903-2911

  Robinson, D Ashley ^a   Sutcliffe, Joyce A ^b   Tewodros, Wezenet ^a,c   Manoharan, Anand ^a,d   Bessen, Debra E ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b Rib X Pharmaceuticals Incorporated   (United States)

^c West Indies   (Saint Lucia)

^d CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; ERYTHROMYCIN; MACROLIDE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIUM ISOLATE; EMM GENE; ERM A GENE; ERM B GENE; GENE MUTATION; GENETIC RECOMBINATION; GEOGRAPHIC DISTRIBUTION; MACROLIDE RESISTANT STREPTOCOCCUS GROUP A; MEF A GENE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STRAIN IDENTIFICATION; STREPTOCOCCUS GROUP A;

BIOLOGICAL EVOLUTION; DISEASE TRANSMISSION; DISEASE TRANSMISSION, INFECTIOUS; DRUG RESISTANCE, BACTERIAL; EVOLUTION; GENE TRANSFER, HORIZONTAL; GENETIC VARIATION; HUMANS; MACROLIDES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; VARIATION (GENETICS); VIRULENCE;

EID: 33748691427     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00325-06     Document Type: Article

References (58)

1. Aanensen, D. M. December 2005, posting date. Multi locus sequence typing. [Online.] http://spyogenes.mlst.net.
2. Alos, J. I., B. Aracil, J. Oteo, J. L. Gomez-Garces, and the Spanish Group for the Study of Infection in the Primary Health Care Setting (IAP-SEIMC). 2003. Significant increase in the prevalence of erythromycin-resistant, clindamycin-and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain. J. Antimicrob. Chemother. 51:333-337.
3. Banks, D. J., S. F. Porcella, K. D. Barbian, J. M. Martin, and J. M. Musser. 2003. Structure and distribution of an unusual chimeric genetic element encoding macrolide resistance in phylogenetically diverse clones of group A streptococcus. J. Infect. Dis. 188:1898-1908.
4. Beall, B. 2006. Streptococcus pyogenes emm sequence database. Centers for Disease Control and Prevention, Atlanta, Ga. [Online.] http://www.cdc.gov /ncidod/biotech/strep/emmtypes.htm.
5. Bessen, D. E., and A. Kalia. 2002. Genomic localization of a T-serotype locus to a recombinatorial zone encoding for extracellular matrix-binding proteins in Streptococcus pyogenes. Infect. Immun. 70:1159-1167.
6. Bisno, A. L., and D. Stevens. 2000. Streptococcus pyogenes (Including streptococcal toxic shock syndrome and necrotizing fasciitis), p. 2101-2117. In G. L. Mandell, R. G. Douglas, and R. Dolin (ed.), Principles and practice of infectious diseases, 5th ed., vol. 2. Churchill Livingstone, Philadelphia, Pa.
7. De Azavedo, J. C., R. H. Yeung, D. J. Bast, C. L. Duncan, S. B. Borgia, and D. E. Low. 1999. Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada. Antimicrob. Agents Chemother. 43:2144-2147.
8. Enright, M. C., B. G. Spratt, A. Kalia, J. H. Cross, and D. E. Bessen. 2001. Multilocus sequence typing of Streptococcus pyogenes and the relationship between emm type and clone. Infect. Immun. 69:2416-2427.
9. Facinelli, B., C. Spinaci, G. Magi, E. Giovanetti, and P. E. Varaldo. 2001. Association between erythromycin resistance and ability to enter human respiratory cells in group A streptococci. Lancet 358:30-33.
10. Farrell, D. J., I. Morrissey, S. Bakker, and D. Felmingham. 2002. Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study. J. Antimicrob. Chemother. 50:39-47.
11. Farrell, D. J., J. Shackcloth, K. A. Barbadora, and M. D. Green. 2006. Streptococcus pyogenes isolates with high-level macrolide resistance and reduced susceptibility to telithromycin associated with 23S rRNA mutations. Antimicrob. Agents Chemother. 50:817-818.
12. Feil, E. J., E. C. Holmes, D. E. Bessen, M.-S. Chan, N. P. J. Day, M. C. Enright, R. Goldstein, D. Hood, A. Kalia, C. E. Moore, J. Zhou, and B. G. Spratt. 2001. Recombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequences. Proc. Natl. Acad. Sci. USA. 98:182-187.
13. Feil, E. J., B. C. Li, D. M. Aanensen, W. P. Hanage, and B. G. Spratt. 2004. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J. Bacteriol. 186:1518-1530.
14. Freeman, A. F., and S. T. Shulman. 2002. Macrolide resistance in group A Streptococcus. Pediatr. Infect. Dis. J. 21:1158-1160.
15. Fujita, K., K. Murono, M. Yoshikawa, and T. Murai. 1994. Decline of erythromycin resistance of group A streptococci in Japan. Pediatr. Infect. Dis. J. 13:1075-1078.
16. Garcia-Bustos, J., and A. Tomasz. 1990. A biological price of antibiotic resistance: major changes in the peptidoglycan structure of penicillin-resistant pneumococci. Proc. Natl. Acad. Sci. USA 87:5415-5419.
17. Garcia-Rey, C., L. Aguilar, F. Baquero, J. Casal, and J. E. Martin. 2002. Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain. J. Clin. Microbiol. 40:2959-2963.
18. Giovanetti, E., A. Brenciani, M. Vecchi, A. Manzin, and P. E. Varaldo. 2005. Prophage association of mef(A) elements encoding efflux-mediated erythromycin resistance in Streptococcus pyogenes. J. Antimicrob. Chemother. 55:445-451.
19. Gooskens, J., A. J. De Neeling, R. J. Willems, J. W. Van't Wout, and E. J. Kuijper. 2005. Streptococcal toxic shock syndrome by an iMLS resistant M type 77 Streptococcus pyogenes in the Netherlands. Scand. J. Infect. Dis. 37:85-89.
20. Grundmann, H., S. Hori, and G. Tanner. 2001. Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms. J. Clin. Microbiol. 39:4190-4192.
21. Hanage, W. P., C. Fraser, and B. G. Spratt. 2006. The impact of homologous recombination on the generation of diversity in bacteria. J. Theor. Biol. 239:210-219.
22. Horn, D., J. Zabriskie, R. Austrian, P. Cleary, J. Ferretti, V. Fischetti, E. Gotschlich, E. Kaplan, M. McCarty, S. Opal, R. Roberts, A. Tomasz, and Y. Wachtfogel. 1998. Why have group A streptococci remained susceptible to penicillin? Report on a symposium. Clin. Infect. Dis. 26:1341-1345.
23. Hunter, P. R., and M. A. Gaston. 1988. Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity. J. Clin. Microbiol. 26:2465-2466.
24. Kalia, A., M. C. Enright, B. G. Spratt, and D. E. Bessen. 2001. Directional gene movement from human-pathogenic to commensal-like streptococci. Infect. Immun. 69:4858-4869.
25. Kalia, A., B. G. Spratt, M. C. Enright, and D. E. Bessen. 2002. Influence of recombination and niche separation on the population genetic structure of the pathogen Streptococcus pyogenes. Infect. Immun. 70:1971-1983.
26. Kaplan, E. L., and D. R. Johnson. 2001. Unexplained reduced microbiological efficacy of intramuscular benzathine penicillin G and of oral penicillin V in eradication of group a streptococci from children with acute pharyngitis. Pediatrics 108:1180-1186.
27. Katz, K. C., A. J. McGeer, C. L. Duncan, A. Ashi-Sulaiman, B. M. Willey, A. Sarabia, J. McCann, S. Pong-Porter, Y. Rzayev, J. S. de Azavedo, and D. E. Low. 2003. Emergence of macrolide resistance in throat culture isolates of group A streptococci in Ontario, Canada, in 2001. Antimicrob. Agents Chemother. 47:2370-2372.
28. Krebs, C. J. 1989. Ecological methodology. Harper and Row, New York, N.Y.
29. Leclercq, R., and P. Courvalin. 1991. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob. Agents Chemother. 35:1267-1272.
30. Levin, B. R., V. Perrot, and N. Walker. 2000. Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. Genetics 154:985-997.
31. Li, Z. Y., V. Sakota, D. Jackson, A. R. Franklin, and B. Beall. 2003. Array of M protein gene subtypes in 1064 recent invasive group a streptococcus isolates recovered from the active bacterial core surveillance. J. Infect. Dis. 188:1587-1592.
32. Lowbury, E. J. L., and L. Hurst. 1959. The sensitivity of staphylococci and other wound bacteria to erythromycin, oleandomycin and spiramycin. J. Clin. Pathol. 12:163-169.
33. Malbruny, B., K. Nagai, M. Coquemont, B. Bozdogan, A. T. Andrasevic, H. Hupkova, R. Leclercq, and P. C. Appelbaum. 2002. Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutations. J. Antimicrob. Chemother. 49:935-939.
34. Martin, J. M., M. Green, K. A. Barbadora, and E. R. Wald. 2002. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh. N. Engl. J. Med. 346:1200-1206.
35. Maruyama, S., H. Yoshioka, K. Fujita, M. Takimoto, and Y. Satake. 1979. Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan. Am. J. Dis. Child 133:1143-1145.
36. McGregor, K., N. Bilek, A. Bennett, A. Kalia, B. Beall, J. Carapetis, B. Currie, K. Sriprakash, B. Spratt, and D. Bessen. 2004. Group A streptococci from a remote community have novel multilocus genotypes but share emm types and housekeeping alleles. J. Infect. Dis. 189:717-723.
37. McGregor, K. F., and B. G. Spratt. 2005. Identity and prevalence of multilocus sequence typing-defined clones of group A streptococci within a hospital setting. J. Clin. Microbiol. 43:1963-1967.
38. McGregor, K. F., B. G. Spratt, A. Kalia, A. Bennett, N. Bilek, B. Beall, and D. E. Bessen. 2004. Multilocus sequence typing of Streptococcus pyogenes representing most known emm types and distinctions among subpopulation genetic structures. J. Bacteriol. 186:4285-4294.
39. Neeman, R., N. Keller, A. Barzilai, Z. Korenman, and S. Sela. 1998. Prevalence of internalisation-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers. Lancet 352:1974-1977.
40. Nei, M. 1987. Molecular evolutionary genetics. Columbia University Press, New York, N.Y.
41. Perez-Trallero, E., C. Fernandez-Mazarrasa, C. Garcia-Rey, E. Bouza, L. Aguilar, J. Garcia-de-Lomas, and F. Baquero. 2001. Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob. Agents Chemother. 45:3334-3340.
42. Pfister, P., N. Corti, S. Hobbie, C. Bruell, R. Zarivach, A. Yonath, and E. C. Bottger. 2005. 23S rRNA base pair 2057-2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A→G Proc. Natl. Acad. Sci. USA 102:5180-5185.
43. Reinert, R. R., R. Lutticken, J. A. Sutclifle, A. Tait-Kamradt, M. Y. Cil, H. M. Schorn, A. Bryskier, and A. Al-Lahham. 2004. Clonal relatedness of erythromycin-resistant Streptococcus pyogenes isolates in Germany. Antimicrob. Agents Chemother. 48:1369-1373.
44. Richter, S. S., K. P. Heilmann, S. E. Beekmann, N. J. Miller, A. L. Miller, C. L. Rice, C. D. Doern, S. D. Reid, and G. V. Doern. 2005. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003. Clin. Infect. Dis. 41:599-608.
45. Robinson, D. A., and M. C. Enright. 2003. Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 47:3926-3934.
46. Sangvik, M., P. Littauer, G. S. Simonsen, A. Sundsfjord, and K. H. Dahl. 2005. mef(A), mef(E) and a new mef allele in macrolide-resistant Streptococcus spp. isolates from Norway. J. Antimicrob. Chemother. 56:841-846.
47. Santagati, M., F. Iannelli, C. Cascone, F. Campanile, M. R. Oggioni, S. Stefani, and G. Pozzi. 2003. The novel conjugative transposon Tn1207.3 carries the macrolide efflux gene mef(A) in Streptococcus pyogenes. Microb. Drug Resist. Mech. Epidemiol. Dis. 9:243-247.
48. Santagati, M., F. Iannelli, M. R. Oggioni, S. Stefani, and G. Pozzi. 2000. Characterization of a genetic element carrying the macrolide efflux gene mef(A) in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 44:2585-2587.
49. Schalen, C., D. Gebreselassie, and S. Stahl. 1995. Characterization of an erythromycin resistance (erm) plasmid in Streptococcus pyogenes. APMIS 103:59-68.
50. Seppala, H., T. Klaukka, J. Vuopio-Varkila, A. Muotiala, H. Helenius, K. Lager, P. Huovinen, and Finnish Study Group for Antimicrobial Resistance. 1997. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N. Engl. J. Med. 337:441-446.
51. Seppala, H., M. Skurnik, H. Soini, M. C. Roberts, and P. Huovinen. 1998. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob. Agents Chemother. 42:257-262.
52. Spigaglia, P., F. Barbanti, and P. Mastrantonio. 2005. Horizontal transfer of erythromycin resistance from Clostridium difficile to Butyrivibrio fibrisolvens. Antimicrob. Agents Chemother. 49:5142-5145.
53. Sutcliffe, J., T. Grebe, A. Tait-Kamradt, and L. Wondrack. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother, 40:2562-2566.
54. Sutclifie, J., A. Tait-Kamradt, and L. Wondrack. 1996. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40:1817-1824.
55. Szczypa, K., E. Sadowy, R. Izdebski, and W. Hryniewicz. 2004. A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002. J. Antimicrob. Chemother. 54:828-831.
56. Tanz, R. R., S. T. Shulman, V. D. Shortridge, W. Kabat, K. Kabat, E. Cederlund, J. Rippe, J. Beyer, S. Doktor, and B. W. Beall. 2004. Community-based surveillance in the United States of macrolide-resistant pediatric pharyngeal group a streptococci during 3 respiratory disease seasons. Clin. Infect. Dis. 39:1794-1801.
57. Woo, P. C. Y., A. P. C. To, H. Tse, S. K. P. Lau, and K. Y. Yuen. 2003. Clinical and molecular epidemiology of erythromycin-rcsistant beta-hemolytic Lancefield group G streptococci causing bacteremia. J. Clin. Microbiol. 41:5188-5191.
58. Yan, J. J., H. M. Wu, A. H. Huang, H. M. Fu, C. T. Lee, and J. J. Wuz. 2000. Prevalence of polyclonal mef(A)-containing isolates among erythromycin-resistant group A streptococci in southern Taiwan. J. Clin. Microbiol. 38:2475-2479.